| UBS (LUX) EQUITY SICAV - ALL CHINA (USD) Q-ACC | RVI CHINA | 3,63% | 7,95% | -33,62% | · |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 25,25% | 13,79% | -33,71% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I2 CHF | SALUD | 3,87% | -10,63% | -33,72% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I2 USD | SALUD | 4,39% | -11,50% | -33,72% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I2 EUR | SALUD | 4,26% | -10,70% | -33,73% | · |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I EUR | SALUD | 4,22% | -10,79% | -33,74% | · |
| TEMPLETON CHINA W (YDIS) EUR | RVI CHINA | 9,84% | 11,45% | -33,76% | 38,06% |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I USD | SALUD | 4,35% | -11,59% | -33,77% | · |
| TEMPLETON CHINA W (ACC) EUR | RVI CHINA | 9,85% | 11,50% | -33,77% | 44,34% |
| BELLEVUE FUNDS (LUX) - BELLEVUE ASIA PACIFIC HEALTHCARE I CHF | SALUD | 3,83% | -10,78% | -33,85% | · |
